Abcuro, Inc.
through Aug 13, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 19, 2025 · D | Aug 13, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $199,999,869 | $176,522,953 | $-23,476,916 |
| Reported amount sold | $79,999,955 | $39,383,108 | $-40,616,847 |
| Reported investor count | — | 23 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001692147-25-000003 · Later SEC source: 0001692147-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $176,522,953
- Reported amount sold
- $39,383,108
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001692147-26-000001D · Aug 13, 2026 · BiotechnologyOffering: $176,522,953Sold: $39,383,108
-
0001692147-25-000003D · Feb 19, 2025 · BiotechnologyOffering: $199,999,869Sold: $79,999,955